| DNA Fountain enables a robust and efficient storage architecture Y Erlich, D Zielinski science 355 (6328), 950-954, 2017 | 928 | 2017 |
| Genome-wide profiling of heritable and de novo STR variations T Willems, D Zielinski, J Yuan, A Gordon, M Gymrek, Y Erlich Nature methods 14 (6), 590-592, 2017 | 278 | 2017 |
| COVID-19 pandemic and worldwide organ transplantation: a population-based study O Aubert, D Yoo, D Zielinski, E Cozzi, M Cardillo, M Dürr, ... The Lancet Public Health 6 (10), e709-e719, 2021 | 218 | 2021 |
| BAP1 complex promotes transcription by opposing PRC1-mediated H2A ubiquitylation A Campagne, MK Lee, D Zielinski, A Michaud, S Le Corre, F Dingli, ... Nature communications 10 (1), 348, 2019 | 141 | 2019 |
| EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells R Ragazzini, R Pérez-Palacios, IH Baymaz, S Diop, K Ancelin, D Zielinski, ... Nature communications 10 (1), 3858, 2019 | 105 | 2019 |
| The Banff 2022 Kidney Meeting Report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics M Naesens, C Roufosse, M Haas, C Lefaucheur, RB Mannon, BA Adam, ... American Journal of Transplantation 24 (3), 338-349, 2024 | 78 | 2024 |
| A cis-acting mechanism mediates transcriptional memory at Polycomb target genes in mammals D Holoch, M Wassef, C Lövkvist, D Zielinski, S Aflaki, B Lombard, T Héry, ... Nature Genetics 53 (12), 1686-1697, 2021 | 67 | 2021 |
| EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer M Wassef, A Luscan, S Aflaki, D Zielinski, PWTC Jansen, HI Baymaz, ... Proceedings of the National Academy of Sciences 116 (13), 6075-6080, 2019 | 60 | 2019 |
| OTX2 duplication is implicated in hemifacial microsomia D Zielinski, B Markus, M Sheikh, M Gymrek, C Chu, M Zaks, B Srinivasan, ... PloS one 9 (5), e96788, 2014 | 59 | 2014 |
| DNA. Land is a framework to collect genomes and phenomes in the era of abundant genetic information J Yuan, A Gordon, D Speyer, R Aufrichtig, D Zielinski, J Pickrell, Y Erlich Nature genetics 50 (2), 160-165, 2018 | 32 | 2018 |
| Complicated legacies: The human genome at 20 KM Jones, R Cook-Deegan, CN Rotimi, SL Callier, AR Bentley, H Stevens, ... Science 371 (6529), 564-569, 2021 | 25 | 2021 |
| Highly efficient de novo mutant identification in a Sorghum bicolor TILLING population using the ComSeq approach H Nida, S Blum, D Zielinski, DA Srivastava, R Elbaum, Z Xin, Y Erlich, ... The Plant Journal 86 (4), 349-359, 2016 | 25 | 2016 |
| iPipet: sample handling using a tablet D Zielinski, A Gordon, BL Zaks, Y Erlich Nature methods 11 (8), 784-785, 2014 | 16 | 2014 |
| Biological screens from linear codes: theory and tools Y Erlich, A Gilbert, H Ngo, A Rudra, N Thierry-Mieg, M Wootters, ... BioRxiv, 035352, 2015 | 15 | 2015 |
| Locus specific epigenetic modalities of random allelic expression imbalance L Marion-Poll, B Forêt, D Zielinski, F Massip, M Attia, AC Carter, L Syx, ... Nature Communications 12 (1), 5330, 2021 | 13 | 2021 |
| Microarray-based comparative genomic hybridization, multiplex ligation-dependent probe amplification, and high-resolution karyotype for differential diagnosis … AB Glaeser, BL Diniz, D Deconte, AS Santos, RFM Rosa, PRG Zen Journal of Pediatric Genetics 9 (03), 149-157, 2020 | 7 | 2020 |
| Banff human organ transplant consensus gene panel for the detection of antibody mediated rejection in heart allograft biopsies A Giarraputo, G Coutance, O Aubert, M Fedrigo, F Mezine, D Zielinski, ... Transplant International 36, 11710, 2023 | 6 | 2023 |
| Back to the family: a renewed approach to rare variant studies D Zielinski, M Gymrek, Y Erlich Genome Medicine 4, 1-3, 2012 | 6 | 2012 |
| Spatio-temporal X-linked gene reactivation and site-specific retention of epigenetic silencing in the mouse germline C Roidor, L Syx, E Beyne, D Zielinski, A Teissandier, C Lee, M Walter, ... bioRxiv, 2023.04. 25.532252, 2023 | 3 | 2023 |
| Genetic privacy in the post-COVID world D Zielinski, Y Erlich Science 371 (6529), 566, 2021 | 1 | 2021 |
Yaniv ErlichCEO, Eleven TherapeuticsBestätigte E-Mail-Adresse bei cs.columbia.edu
